🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Delighted to present my PhD research on KRAS inhibitors and HDAC6 inhibitors on LKB1 mutant driven NSCLC at the #EACR-#AACR-#IACR 2024. Huge thank you to our funders #midwesterncancer and to my supervisor CatríonaMDowling PhD !!

Thrilled to have the opportunity to present my research at #EHA2024 this work would not be possible without Breakthrough Cancer Research and HealthResearchBoard Looking forward to the next 2 days! 🧬👩🏻‍🔬🩸

2 days until the Irish Cancer Society Colour Dash, any donations for our RCSI-Beaumont group are much appreciated 👏 Beaumont RCSI Cancer Centre RCSI fundraise.cancer.ie/fundraisers/RC…

What a fun morning at the Irish Cancer Society Colour Dash 🎨 raising some funds for a wonderful cause with these amazing ladies! Any donations are greatly appreciated: fundraise.cancer.ie/fundraisers/RC… Sandra Hembrecht Róisín McAvera

I was delighted to have the opportunity to speak at the recent Soapbox event on South King St, Dublin. I had the chance to speak about genetics and some of my own lung cancer research. Couldn’t recommend it enough! #soapboxscience

Delighted to share my research with the public at #EuropeanResearchNight on Friday! It was a special way to end #BloodCancerAwareness Month. Thanks to everyone who stopped by, and of course to our funders, Breakthrough Cancer Research & HealthResearchBoard, for making this possible Myeloma Ireland

Excited to share that I presented my PhD research on blunting cell proliferation in High Risk Myeloma and was honored with the Sheppard Prize for Translational Research👩🏽‍🔬🧬💊 Grateful to everyone involved! Siobhan Glavey Breakthrough Cancer Research HealthResearchBoard

A really proud week for our small but powerful team in the myeloma research lab Beaumont RCSI Cancer Centre - Róisín McAvera winning Presidents prize at HAI for her work in risk profiling Irish patients with myeloma #mmsm

Wow! What a week it’s been😁 honoured to receive the best poster prize at this year’s #HAI Breakthrough Cancer Research Myeloma Ireland 🩸🧬👩🏽‍🔬

Less than a week until my first half marathon 🤞🏃‍♀️ I'm doing it in aid of Myeloma Ireland 🩸Any donations would be greatly appreciated, to contribute to well-needed research eventmaster.ie/fundraising/pa…

Such a fun morning cheering on Dr. Róisín McAvera at the Clontarf Half Marathon yesterday, all in support of the incredible work by Myeloma Ireland. So proud of you Ro❤️🥇🏃‍♀️ #MyelomaAwareness

Spread the word about the Bone Marrow for Leukemia Trust cards Tnx. Hayley Foy-Stones Fiona mc auley Carmel Ann Galligan Emma M. Groarke Naomi Algeo Seamus O’Reilly MD PhD Angela Clayton-Lea Jillian Coll Niamhmcauley Siobhan Glavey

Thrilled to share that my first review article has been published in EJH📄It explores emerging drug targets on chromosome 1, with potential to benefit high-risk Myeloma patients. If you’re interested please check it out below: doi.org/10.1111/ejh.14… Breakthrough Cancer Research

My 12th randomized trial. #ASH24 Proud of this one 👇

Targeting chromosome 1 in myeloma could be impactful in high-risk patients - PhD student Niamhmcauley reviews this topic in European Journal of Haematology out now Beaumont RCSI Cancer Centre eJHaem Journal Breakthrough Cancer Research

Delighted to have the opportunity to present my research at the ESH (Haematology) Conference in Vienna. Looking forward to hearing the experts over the following days! Thanks as always to Breakthrough Cancer Research for supporting this research #highriskMM

Great work by Robyn Stanley presenting her work on #lungcancer at #AACR2025 Beaumont RCSI Cancer Centre RCSI

The inaugural meeting of ⁦Irish Multiple Myeloma Society⁩ will take place September 12th in Dublin. Open to HCPs/trainees working with myeloma patients, a wonderful panel of speakers promises to make this a great meeting 🇮🇪 #mmsm

An exciting day today at the Beaumont RCSI Cancer Centre RCSI Conference! So grateful to learn from leaders and innovators in the field 🧬🔬 Thanks to Breakthrough Cancer Research for supporting this research

Breaking: Big news for smoldering myeloma. The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended the approval of a new indication for DARZALEX®(daratumumab) subcutaneous (SC) formulation as monotherapy for the treatment